Nyxoah S.A. (NYXH)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$2.99
-0.50%
Mkt Cap $132.95M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | $5.39M | $6.63M | +23.08% | -$0.65 | -$0.68 | -4.62% | — | — |
| Q4 2025 Nov 13, 2025 | $5.68M | $2.31M | -59.37% | -$0.61 | -$0.74 | -21.31% | — | — |
| Q3 2025 Aug 18, 2025 | $2.66M | $1.58M | -40.70% | -$0.62 | -$0.63 | -1.61% | — | — |
| Q2 2025 May 14, 2025 | $1.47M | $1.17M | -20.50% | -$0.49 | -$0.63 | -28.57% | — | — |
| Q1 2025 Mar 13, 2025 | $2.36M | $1.31M | -44.64% | -$0.46 | -$0.49 | -6.52% | — | — |
| Q4 2024 Nov 6, 2024 | $2.01M | $1.39M | -31.08% | -$0.46 | -$0.55 | -19.57% | — | — |
| Q3 2024 Aug 6, 2024 | $1.96M | $829.01K | -57.70% | -$0.45 | -$0.46 | -2.22% | — | — |
| Q2 2024 May 14, 2024 | $1.29M | $1.31M | +1.68% | -$0.45 | -$0.45 | +0.00% | — | — |
| Q1 2024 Mar 5, 2024 | $1.92M | $2.01M | +4.73% | -$0.41 | -$0.41 | +0.00% | — | — |
| Q4 2023 Nov 8, 2023 | $1.46M | $1.03M | -29.64% | -$0.48 | -$0.29 | +39.58% | — | — |
| Q3 2023 Aug 8, 2023 | $1.18M | $1.21M | +2.36% | -$0.45 | -$0.49 | -8.89% | — | — |
| Q2 2023 May 16, 2023 | $1.31M | $479.46K | -63.50% | -$0.37 | -$0.49 | -32.43% | — | — |
| Q1 2023 Mar 22, 2023 | $3.17M | $1.41M | -55.65% | -$0.28 | -$0.52 | -85.71% | — | — |
| Q4 2022 Nov 8, 2022 | $1.37M | $177.74K | -87.02% | -$0.30 | -$0.24 | +20.00% | — | — |
| Q3 2022 Aug 8, 2022 | $1.11M | $978.03K | -11.57% | -$0.32 | -$0.21 | +34.38% | — | — |
| Q2 2022 May 9, 2022 | $517.92K | $730.04K | +40.96% | -$0.26 | -$0.29 | -11.54% | — | — |
| Q1 2022 Mar 25, 2022 | $620.00K | $334.44K | -46.06% | -$0.27 | -$0.28 | -2.06% | — | — |
| Q4 2021 Nov 25, 2021 | — | $235.62K | — | -$0.23 | -$0.40 | -75.48% | — | — |
| Q3 2021 Aug 31, 2021 | $187.00K | $201.69K | +7.86% | -$0.19 | -$0.38 | -100.00% | — | — |
| Q2 2021 Jun 10, 2021 | — | $217.59K | — | — | -$0.30 | — | — | — |